This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
Company will showcase new safety introducer needle and portfolio of bulk, non-sterile needles
(PRWEB) November 30, 2012
B. Braun OEM Division (http://www.bbraunoem.com) will attend the BIOMEDevice Regional Conference at the San Jose McEnery Convention Center in San Jose, Calif., on December 4-5, 2012, and exhibit the company’s products for contract manufacturing of medical devices and procedure kits.
B. Braun OEM Division (Booth 317) will promote products within the following categories: fluid administration and management products, valves, admixture devices, interventional accessories, catheters and custom kits. B. Braun will also feature its new Safecan™ Safety Introducer Needle, as well as its new portfolio of bulk, non-sterile needles.
The 2012 BIOMEDevice Meeting (http://www.canontradeshows.com/expo/biomed11/) will host more than 3,500 regional medtech OEM representatives to share tips on industry trends and the latest technology in the field. The event exhibits leading edge technology that cannot be found online and provides access to the industry’s top suppliers.
For more information, contact the B. Braun OEM Division toll free at 866-8-BBRAUN or visit http://www.bbraunoem.com.
About B. Braun OEM Division
B. Braun OEM Division (http://www.bbraunoem.com) delivers complete contract manufacturing capabilities focusing on fluid administration and admixture products, kits, valves, catheters and interventional accessories. OEM takes customers’ designs from the earliest stages through design prototyping, assembly, packaging and sterilization. The B. Braun OEM Division of B. Braun Medical Inc. is based in Bethlehem, Pa.
About B. Braun
Since the early 19th Century, B. Braun has met a myriad of challenges in modern medical therapy with meaningful and trusted solutions. The B. Braun group of companies, including B. Braun, Aesculap® and Central Admixture Pharmacy Services, Inc. (CAPS®), represent thousands of innovations in acute pain management and infusion therapy that are intended to improve care and lower costs while reducing risks to patients and workers. Guided by the company’s “Sharing Expertise®” philosophy, B. Braun works with motivated partners and customers to address the critical issues of infection prevention, medication safety and environmental responsibility.
The B. Braun corporate mission to bring solutions that lead to better patient care have earned the company dozens of awards, certifications and recognitions for innovative products, employment practices, “green” initiatives and community responsibility throughout the world. Consistently recognized by Frost & Sullivan for its medical technology and support services, B. Braun provides professional training through its Aesculap Academy, reaching over 45,000 healthcare professionals each year, teaching best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives. For more information, call 800-227-2862, e-mail us at inquiry.us(at)bbraun(dot)com or visit B. Braun at http://www.bbraunusa.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/11/prweb10190488.htm
635 W. 7th Street